FDA Adverse Event Injury Summary report: N

WATCHMAN FLX LEFT ATRIAL APPENDAGE CLOSURE DEVICE WITH DELIVERY SYSTEM

MDR report key: 18304343 · Received December 11, 2023

Report

Report Number
2124215-2023-69618
Event Type
Injury
Date Received
December 11, 2023
Date of Event
October 20, 2023
Report Date
December 11, 2023
Manufacturer
BOSTON SCIENTIFIC CORPORATION
Product Code
NGV
UDI-DI
08714729860495
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
CO, US
Reporter Occupation
PHYSICIAN
Health Professional
Yes

Narratives

Description of Event or Problem · 0

IT WAS REPORTED THAT THROMBOSIS OCCURRED. A LEFT ATRIAL APPENDAGE (LAA) CLOSURE PROCEDURE WAS PERFORMED, AND A 24MM WATCHMAN FLX LAA CLOSURE DEVICE WAS IMPLANTED. COMPUTED TOMOGRAPHY (CT) WAS PERFORMED FORTY-THREE (43) DAYS POST PROCEDURE WHEN THE PATIENT WAS ADMITTED WITH COVID. THE PATIENT DID NOT TAKE HER SIX WEEKS OF ORAL ANTICOAGULATION (OAC) DUE TO HER ILLNESS WITH COVID. THE CT SHOWED A PEDUNCULATED THROMBUS ON THE FACE OF THE THREADED INSERT OF THE CLOSURE DEVICE WHICH WAS BIASED TOWARDS THE LIMBUS. THERE WAS A SMALL SHOULDER WITH A SMALL GUTTER ON THE LIMBUS SIDE OF THE CLOSURE DEVICE. THE PATIENT WAS THEN PLACED ON OAC THERAPY FOR 6 WEEKS. THE PATIENT RETURNED FOR A FOLLOW UP TRANSESOPHAGEAL ECHOCARDIOGRAPHY (TEE) IMAGING, WHICH SHOWED THAT THE CLOT HAD APPEARED TO HAVE SHRUNK IN SIZE. THE PATIENT WAS TO CONTINUE OACS FOR APPROXIMATELY THREE MORE WEEKS TO DISSOLVE THE REMAINING THROMBUS AND THEN PERFORM A REPEAT CT. NO FURTHER PATIENT COMPLICATIONS WERE REPORTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1214115 WATCHMAN FLX LEFT ATRIAL APPENDAGE CLOSURE DEVICE WITH DELIVERY SYSTEM SYSTEM, APPENDAGE CLOSURE, LEFT ATRIAL NGV BOSTON SCIENTIFIC CORPORATION 10390 0031385898 08714729860495

Patients

Seq Age Sex Outcome Treatment
1 Female Other